BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6086246)

  • 1. In vitro susceptibility studies with oxiconazole (Ro 13-8996).
    Gebhart RJ; Espinel-Ingroff A; Shadomy S
    Chemotherapy; 1984; 30(4):244-7. PubMed ID: 6086246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro comparison of the antifungal activities of R34,000, miconazole and amphotericin B.
    Dixon DM; Wagner GE; Shadomy S; Shadomy HJ
    Chemotherapy; 1978; 24(6):364-7. PubMed ID: 699677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
    Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
    Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents.
    Odds FC; Webster CE; Abbott AB
    J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro sensitivity of environmental isolates of pathogenic dematiaceous fungi to azole compounds and a phenylpropyl-morpholine derivative.
    Okeke CN; Gugnani HC
    Mycopathologia; 1987 Sep; 99(3):175-81. PubMed ID: 3657909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies of a new imidazole antimycotic, bifonazole, in comparison with clotrimazole and miconazole.
    Yamaguchi H; Hiratani T; Plempel M
    Arzneimittelforschung; 1983; 33(4):546-51. PubMed ID: 6683531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
    Odds FC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):763-70. PubMed ID: 6295266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disk diffusion susceptibility testing of dermatophytes with imidazoles.
    Venugopal PV; Venugopal TV
    Indian J Pathol Microbiol; 1995 Oct; 38(4):369-74. PubMed ID: 9726146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
    Uchida K; Matsuzaka A; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):562-70. PubMed ID: 1652654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses].
    Uchida K; Hosaka J; Aoki K; Yamaguchi H
    Jpn J Antibiot; 1991 May; 44(5):571-9. PubMed ID: 1652655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A facile synthesis of novel miconazole analogues and the evaluation of their antifungal activity.
    Ramírez-Villalva A; González-Calderón D; González-Romero C; Morales-Rodríguez M; Jauregui-Rodríguez B; Cuevas-Yáñez E; Fuentes-Benítes A
    Eur J Med Chem; 2015 Jun; 97():275-9. PubMed ID: 25989345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activities of polyene and imidazole antifungal agents against unusual opportunistic fungal pathogens.
    Rotowa NA; Shadomy HJ; Shadomy S
    Mycoses; 1990 Apr; 33(4):203-11. PubMed ID: 2233893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further in vitro studies with oxiconazole nitrate.
    Shadomy S; Wang H; Shadomy HJ
    Diagn Microbiol Infect Dis; 1988 Apr; 9(4):231-7. PubMed ID: 3180708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro studies with R 51,211 (itraconazole).
    Espinel-Ingroff A; Shadomy S; Gebhart RJ
    Antimicrob Agents Chemother; 1984 Jul; 26(1):5-9. PubMed ID: 6089654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole.
    Eng RH; Person A; Mangura C; Chmel H; Corrado M
    Antimicrob Agents Chemother; 1981 Nov; 20(5):688-90. PubMed ID: 6275783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
    Hernández Molina JM; Llosá J; Martinez Brocal A; Ventosa A
    Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimycotic susceptibility testing of agents of black grain eumycetoma.
    Venugopal PV; Venugopal TV; Ramakrishna ES; Ilavarasi S
    J Med Vet Mycol; 1993; 31(2):161-4. PubMed ID: 8389847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients.
    Moody MR; Young VM; Morris MJ; Schimpff SC
    Antimicrob Agents Chemother; 1980 May; 17(5):871-5. PubMed ID: 6249197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: BAY n 7133 and BAY 1 9139.
    Fromtling RA; Yu HP; Shadomy S
    Sabouraudia; 1983 Sep; 21(3):179-84. PubMed ID: 6314564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400.
    Dixon D; Shadomy S; Shadomy HJ; Espinel-Ingroff A; Kerkering TM
    J Infect Dis; 1978 Aug; 138(2):245-8. PubMed ID: 681800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.